Useful Links
Biology
Cell Biology
Cancer Biology
1. Introduction to Cancer Biology
2. The Molecular and Cellular Basis of Cancer
3. The Genetic and Epigenetic Landscape of Cancer
4. The Hallmarks of Cancer
5. Tumor Microenvironment
6. Invasion and Metastasis
7. Cancer Diagnosis and Staging
8. Cancer Treatment Principles
9. Cancer Prevention and Control
Cancer Treatment Principles
Conventional Therapies
Surgical Oncology
Principles of Cancer Surgery
Complete Resection
Adequate Margins
Lymph Node Assessment
Types of Surgical Procedures
Curative Surgery
Palliative Surgery
Reconstructive Surgery
Preventive Surgery
Minimally Invasive Techniques
Laparoscopic Surgery
Robotic Surgery
Endoscopic Procedures
Surgical Complications
Immediate Complications
Long-term Sequelae
Chemotherapy
Mechanisms of Action
DNA Damage Induction
Alkylation
Crosslinking
Strand Breaks
Antimetabolite Effects
Nucleotide Synthesis Inhibition
DNA Synthesis Disruption
Mitotic Inhibition
Microtubule Disruption
Spindle Formation Interference
Topoisomerase Inhibition
DNA Unwinding Disruption
Replication Fork Collapse
Drug Classifications
Alkylating Agents
Nitrogen Mustards
Nitrosoureas
Platinum Compounds
Antimetabolites
Folate Antagonists
Purine Analogs
Pyrimidine Analogs
Antitumor Antibiotics
Anthracyclines
Bleomycin
Mitomycin C
Plant Alkaloids
Vinca Alkaloids
Taxanes
Podophyllotoxins
Topoisomerase Inhibitors
Type I Inhibitors
Type II Inhibitors
Administration Routes
Intravenous
Oral
Intrathecal
Intraperitoneal
Combination Chemotherapy
Synergistic Effects
Non-overlapping Toxicities
Resistance Prevention
Toxicity Management
Acute Toxicities
Nausea and Vomiting
Myelosuppression
Mucositis
Chronic Toxicities
Cardiotoxicity
Neurotoxicity
Secondary Malignancies
Radiation Therapy
Biological Effects
Direct DNA Damage
Indirect DNA Damage
Oxygen Enhancement Ratio
Relative Biological Effectiveness
Types of Radiation
External Beam Radiation
Photon Beams
Electron Beams
Proton Beams
Heavy Ion Beams
Internal Radiation
Brachytherapy
Radiopharmaceuticals
Treatment Planning
Target Volume Definition
Dose Distribution
Normal Tissue Constraints
Fractionation Schemes
Conventional Fractionation
Hypofractionation
Hyperfractionation
Stereotactic Radiosurgery
Radiation Toxicity
Acute Effects
Skin Reactions
Mucositis
Fatigue
Late Effects
Fibrosis
Secondary Cancers
Organ Dysfunction
Targeted Therapy
Small Molecule Inhibitors
Tyrosine Kinase Inhibitors
EGFR Inhibitors
BCR-ABL Inhibitors
VEGFR Inhibitors
Multi-kinase Inhibitors
Serine/Threonine Kinase Inhibitors
mTOR Inhibitors
CDK4/6 Inhibitors
MEK Inhibitors
Other Enzyme Inhibitors
PARP Inhibitors
Proteasome Inhibitors
Histone Deacetylase Inhibitors
Monoclonal Antibodies
Mechanisms of Action
Receptor Blockade
Antibody-Dependent Cellular Cytotoxicity
Complement-Dependent Cytotoxicity
Signal Transduction Interference
Antibody Types
Naked Antibodies
Antibody-Drug Conjugates
Bispecific Antibodies
Immune Checkpoint Inhibitors
Clinical Applications
Growth Factor Receptor Targeting
Angiogenesis Inhibition
Immune System Modulation
Resistance Mechanisms
Primary Resistance
Target Absence
Pathway Redundancy
Compensatory Mechanisms
Acquired Resistance
Target Mutations
Pathway Reactivation
Alternative Pathway Activation
Drug Efflux
Immunotherapy
Immune Checkpoint Blockade
CTLA-4 Inhibition
Mechanism of Action
Clinical Applications
Immune-Related Adverse Events
PD-1/PD-L1 Inhibition
Pathway Biology
Therapeutic Antibodies
Combination Strategies
Other Checkpoint Targets
LAG-3
TIM-3
TIGIT
Adoptive Cell Transfer
Tumor-Infiltrating Lymphocytes
TIL Isolation
Ex Vivo Expansion
Reinfusion Protocols
CAR-T Cell Therapy
CAR Design
T Cell Engineering
Manufacturing Process
Cytokine Release Syndrome
TCR-Engineered T Cells
TCR Identification
T Cell Modification
HLA Restriction
Cancer Vaccines
Preventive Vaccines
HPV Vaccines
Hepatitis B Vaccines
Therapeutic Vaccines
Peptide Vaccines
Dendritic Cell Vaccines
Viral Vector Vaccines
DNA Vaccines
Cytokine Therapy
Interleukin-2
High-Dose IL-2
Low-Dose IL-2
Interferons
Interferon-α
Pegylated Interferons
Immune System Modulators
Immunomodulatory Drugs
Thalidomide Analogs
Checkpoint Agonists
Monoclonal Antibodies
CD20 Targeting
CD52 Targeting
Hormone Therapy
Mechanisms of Action
Hormone Receptor Blockade
Hormone Production Inhibition
Hormone Degradation Enhancement
Breast Cancer Applications
Selective Estrogen Receptor Modulators
Tamoxifen
Raloxifene
Selective Estrogen Receptor Degraders
Fulvestrant
Aromatase Inhibitors
Anastrozole
Letrozole
Exemestane
Prostate Cancer Applications
Androgen Receptor Antagonists
Flutamide
Bicalutamide
Enzalutamide
GnRH Agonists
Leuprolide
Goserelin
CYP17 Inhibitors
Abiraterone
Anti-Angiogenic Therapy
VEGF Pathway Inhibition
Anti-VEGF Antibodies
Bevacizumab
VEGFR Inhibitors
Sunitinib
Sorafenib
Pazopanib
Other Anti-Angiogenic Targets
Angiopoietin Inhibitors
PDGFR Inhibitors
FGF Pathway Inhibitors
Resistance Mechanisms
Alternative Angiogenic Pathways
Vessel Co-option
Increased Pericyte Coverage
Combination Therapies
Rationale for Combinations
Synergistic Effects
Resistance Prevention
Toxicity Reduction
Types of Combinations
Chemotherapy Combinations
Targeted Therapy Combinations
Immunotherapy Combinations
Multimodal Approaches
Sequencing Considerations
Concurrent Administration
Sequential Treatment
Maintenance Therapy
Drug Resistance
Mechanisms of Resistance
Pharmacokinetic Resistance
Drug Absorption
Drug Distribution
Drug Metabolism
Drug Excretion
Pharmacodynamic Resistance
Target Alterations
Pathway Modifications
Cell Death Evasion
Tumor Microenvironment Factors
Hypoxia
pH Changes
Drug Penetration Barriers
Strategies to Overcome Resistance
Combination Therapies
Drug Sequencing
Resistance Monitoring
Novel Drug Development
Previous
7. Cancer Diagnosis and Staging
Go to top
Next
9. Cancer Prevention and Control